… clarified the pathogenesis, at the molecular level, of thyroid carcinomas and … BRAF
V600E-mutated PTC [26] (Table 1). The association of BRAF mutation and PTC at advanced clinical …

… in the pathogenesis of thyroid cancer. As a multi-kinase inhibitor, sorafenib potentially inhibits
… Clinically, BRAF V600E -mutated thyroid cancer cells exhibit primary resistance or poor …

… in clinical research, and explore potentially novel molecular … of BRAF mutation indicate that
the mutation may play a key role … are at the core of TC pathogenesis and progression [11]. …

… discusses the molecular mechanisms associated to the pathogenesis of different types of TC
and their clinical relevance. … BRAF mutations are associated with some histological types of …

… classify the molecular alterations detected in thyroid cancer, … thyroid carcinogenesis that
involve pivotal cellular functions. … The most common BRAF mutation is the V600E substitution, …

… abnormality in the pathogenesis of papillary thyroid carcinoma. We aimed to … Clinical and
histopathological profile of BRAF V600E mutation in conventional papillary thyroid carcinoma …

… of the molecular pathogenesis underlying thyroid cancer … changes in the clinical management
of thyroid nodules, and … the oncogenic role of BRAF V600E and TERTp mutations, it …

… It is frequently activated in thyroid cancer through BRAF mutation, RAS mutation, and RET/…
) BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical …

… in PTC and their correlation with clinical and pathological … family history of thyroid cancer and
BRAF V600E mutation (P = 0.… player in the pathogenesis of PTC, as somatic mutations in its …

… BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical …
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma. Int …